(Q33262597)

English

Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082793%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082793%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082793%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Brouwer E

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082793%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Havenga MJ

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082793%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Ophorst O

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082793%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

de Leeuw B

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082793%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Gijsbers L

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082793%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Gillissen G

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082793%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

ter Horst M

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082793%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Nanda D

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082793%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Dirven C

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082793%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Avezaat CJ

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082793%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Goudsmit J

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082793%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Sillevis Smitt P

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082793%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

3 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082793%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082793%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082793%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082793%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

211-219

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17082793%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Brain tumor survival: results from the National Cancer Data Base

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

Treatment of relapsed malignant glioma with an adenoviral vector containing the herpes simplex thymidine kinase gene followed by ganciclovir

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

An adenovirus vector with a chimeric fiber derived from canine adenovirus type 2 displays novel tropism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

Improved adenovirus vectors for infection of cardiovascular tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

Quantifying Adenovirus-Neutralizing Antibodies by Luciferase Transgene Detection: Addressing Preexisting Immunity to Vaccine and Gene Therapy Vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

Expression of the coxsackie and adenovirus receptor in human astrocytic tumors and xenografts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

CD46 is a cellular receptor for group B adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

Adenovirus type 11 uses CD46 as a cellular receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

Efficient internalization into low-passage glioma cell lines using adenoviruses other than type 5: an approach for improvement of gene delivery to brain tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

Research on complement: old issues revisited and a novel sphere of influence.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

21 January 2018

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701010

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33262597&oldid=2195177467"